Authors
Latest:
Strategies for Independent Pharmacies to Harness Consumer Trends and Meet the CompetitionPharmacies face mounting challenges amid increased competition, rising operational costs, and complex reimbursement models.
Latest:
Lantidra Cell Therapy for Type 1 Diabetes Approved by FDAThe approval was based on safety and efficacy data from 30 participants in 2 open-label, single-arm studies that received 1 to 3 infusions of donislecel.
Latest:
Examining the Risk of Tardive Dyskinesia from AntipsychoticsA recent study highlights the significant frequency of the adverse effect.
Latest:
Reevaluating the Use of Silver Sulfadiazine Cream in the Management of BurnsOne antimicrobial agent commonly used in the management of burns is silver sulfadiazine.
Latest:
Promising Therapies, Treatment Strategies for HR+ Breast Cancer | ASHP MidyearA conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.
Latest:
Q&A: Pharmacists Can Help Women Combat Hidden Heart Disease RisksA conversation with Katherine Tromp, PharmD, interim dean at Northeast Ohio Medical University College of Pharmacy.
Latest:
Molnupiravir: Oral Antiviral for the Treatment of COVID-19Molnupiravir is an oral antiviral for the treatment of mild to moderate COVID-19 in adults at high risk of severe disease.
Latest:
What To Know: FDA Approves Apomorphine for Parkinson DiseaseExpert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
Tips Pharmacists Can Use to Help Women Experiencing Depression | ASHP MidyearA conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.
Latest:
Thermometers: A ReviewPharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Latest:
FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus NephritisThis approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.
Latest:
FDA: Exblifep Approved for Complicated Urinary Tract InfectionsCefepime/enmetazobactam was granted a 5-year exclusivity extension under GAIN Act legislation.
Latest:
More Than Long COVID, There's Flu and Pneumonia TooEpic research suggests that like COVID-19, flu and other viral pneumonias can result in long-term symptoms like fatigue and brain fog. Why that might be is open question.
Latest:
Ethical, Practical Considerations of Exemptions to Employer Vaccine Mandates for AnxietyDoes anxiety justify an exemption from vaccine mandates among health care workers?
Latest:
FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic MelanomaThe FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.
Latest:
Drive Value-based Care With Genetic Testing and Precision MedicineThe shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.
Latest:
COVID-19 Vaccines: A Focus on SafetyEase patients’ concerns by being well versed in the safety profiles of each vaccine.
Latest:
National Pharmacy Chain Opioid Settlements Poised to Affect Independent PharmaciesStipulations of the settlements include data reporting, annual training, and an independent compliance officer.
Latest:
The Effects of “Long COVID” and How Pharmacists Can HelpOften referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
Latest:
The DIR Hangover One Year Later: How Have Pharmacists Fared?Nearly a year after the change to direct and indirect remuneration fees, pharmacy owners talk about how the ruling has impacted their lives.
Latest:
The Impact of COVID-19 on Pharmacy Management and CompliancePharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
Latest:
Misdosing: More Common Than You ThinkUnfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
Latest:
While Telemedicine Decreased After COVID-19 Peak, Mental Health Video Visits RoseCompared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.
Latest:
Patient-First Approach Addresses Unique Needs of Patients With Rare DisordersNow more than ever, 30 million Americans living with a range of 7000 rare or orphan diseases require a high level of therapy adherence support.
Latest:
How This Pharmacist Achieved Dreams of Becoming an Independent OwnerTaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, explored the pharmacy profession from her perspective as an independent owner.
Latest:
Overcoming Vaccine Hesitancy With PatientsPharmacists can work with their patients to address concerns about vaccinations.
Latest:
Belantamab mafodotin-blmf for Relapsed or Refractory Multiple MyelomaBelantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.
Latest:
COVID-19 Vaccine Recommendations Spark Confusion and Trust Concerns, Experts WarnLauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy.
Latest:
The Pipeline Is Full of Expensive, Innovative TherapiesPaying for these new therapies, that may be curative for patients, remains a challenge.
